Clinical trial

Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With…

NCT00352430 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed

Key facts

NCT number NCT00352430
Title Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension
Official title Cardiopulmonary Function Assessment and NO Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension
Lead sponsor National Heart, Lung, and Blood Institute (NHLBI), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Pulmonary Hypertension
Intervention type Drug
Interventions Nitric Oxide/INP Pulse Delivery, Nitric Oxide/INO Pulse Delivery
Enrollment 31
Start date Jul 9, 2006
Primary completion Mar 10, 2010
Completion Mar 10, 2010
First posted Jul 14, 2006
Last update posted Sep 25, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies